734d66e26bc36f75bb371927bfc6.200dspV36Fa5kVWrmDVOaDLNlLZagDD9WRVDMd3YfvI.6DRt6KQwozv74D3s-2cRUF-gw4QL7VbQLjgWS5u2B9-KGEnqokOcLvynOg
11-03 OssDsign AB, Q3 2026 Earnings Call, Nov 03, 2026
11-03 OssDsign AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
09-20 OssDsign AB(OM:OSSD) dropped from S&P Global BMI Index CI
09-09 Ossdsign PROPEL registry surpasses 400 patients FW
08-31 OssDsign: Highlights from DNB Carnegie Micro Cap Day AQ
08-28 Interim Report - January-June 2026 AQ
08-19 DNB Carnegie cuts fair value estimate for OssDsign after earnings report FW
08-19 OssDsign: Growth recovery remains elusive – Q2 review AQ
08-18 AFV: Ossdsign must get sales growth back on track to attract investors FW
08-18 OssDsign AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-18 OssDsign AB, Q2 2026 Earnings Call, Aug 18, 2026
08-18 OssDsign: Q2 initial – Weak quarter as expected AQ
08-18 Ossdsign posts lower revenue and wider operating loss FW
08-18 OssDsign AB (publ) publishes Q2 2026 interim report AQ
08-11 OssDsign: We expect a sluggish Q2, eyeing H2 recovery – Q2 preview AQ
06-25 Ossdsign Appoints Adam McCollister as New Head of Sales FW
06-25 OssDsign appoints Adam McCollister as new Vice President of Sales AQ
06-10 OssDsign AB Elects Per Aniansson as Board Member and Chairman CI
06-10 Annual General Meeting held in OssDsign AB AQ
06-03 Ossdsign announces publication of preclinical study in peer-reviewed scientific journal FW
06-03 Ossdsign raises proposed board remuneration ahead of AGM FW
06-03 OssDsign AB announces updated proposal regarding board fees ahead of the annual general meeting 2026 AQ
05-06 DNB Carnegie lowers fair value for Ossdsign following quarterly report FW
05-06 OssDsign: Needs to prove slowdown is transitional – Q1 review AQ
05-05 OssDsign AB Reports Earnings Results for the First Quarter Ended March 31, 2026 CI

Become a member to access more news

New member
No results match your criteria